The Femtech Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Femtech Market:
https://www.thebusinessresearchcompany.com/report/femtech-global-market-report
According to The Business Research Company’s Femtech Global Market Report 2024, The femtech market size has grown rapidly in recent years. It will grow from $36.52 billion in 2023 to $41.97 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increasing women’s health awareness, changing societal attitudes and taboos, demand for personalized women’s healthcare, shift in women’s health conversations, empowerment and informed decision-making.
The femtech market size is expected to see rapid growth in the next few years. It will grow to $81.24 billion in 2028 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to evolving demographics and aging population, integration of digital health platforms, rise of remote and telehealth services, focus on fertility and reproductive health, preventive and wellness-oriented solutions. Major trends in the forecast period include AI-powered women’s health apps, wearable health devices for women, mental health and wellness apps, digital pelvic floor training, investment in femtech startups.
The rise of digital healthcare is expected to propel the growth of the femtech market. Digital health care technologies use connectivity, software, and sensors for health care and related uses. For instance, in October 2022, according to a report published by the Centers for Disease Control and Prevention, a US-based government agency, 37.0% of adults reported having utilized telemedicine services within the previous 12 months in 2021. Notably, women (42.0%) exhibited a higher likelihood of using telemedicine compared to men (31.7%). Moreover, there was a positive correlation between age and telemedicine usage, with the percentage of adults who engaged in telemedicine rising with age. Specifically, usage rates increased from 29.4% among adults aged 18–29 to 43.3% among adults aged 65 and above. Therefore, the favorable consumer perception and tangible investments in digital health are expected to propel the femtech market growth.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=5890&type=smp
The femtech market covered in this report is segmented –
1) By Type: Devices, Software, Services, Other Types
2) By End Use: Direct-To-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers
3) By Application: Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Healthcare, General Healthcare and Wellness, Other Applications
Major companies operating in the femtech market are developing advanced technologies, such as digital contraceptives, to meet larger customer bases, increase sales, and increase revenue. A digital contraceptive is a medical device that uses self-tracked data and algorithms to identify a menstruator’s fertile window to prevent pregnancy. For instance, in March 2021, Clue, a Germany-based femtech company, announced that it had received U.S. Food and Drug Administration (FDA) clearance to launch Clue Birth Control. The distinctive feature of Clue’s Birth Control is its all-digital contraceptive approach that relies on period tracking data. Through a combination of user menstrual cycle information and Clue’s predictive algorithm, the feature identifies high- or low-risk days for pregnancy. Users can then adjust their behaviors accordingly, with recommendations to abstain from sex or use additional contraception, such as condoms, on high-risk days. As users continue to input data, the algorithm refines its predictions, personalizing them over time and potentially reducing the high-risk window. Notably, Clue’s birth control algorithm is grounded in the Dynamic Optimal Timing (DOT) algorithm, acquired and integrated to enhance the effectiveness of its contraceptive feature.
The femtech market report table of contents includes:
1. Executive Summary
2. Femtech Market Characteristics
3. Femtech Market Trends And Strategies
4. Femtech Market – Macro Economic Scenario
5. Global Femtech Market Size and Growth
.
.
.
26. South America Femtech Market
27. Brazil Femtech Market
28. Middle East Femtech Market
29. Africa Femtech Market
30. Femtech Market Competitive Landscape And Company Profiles
Top Major Players:
- Totohealth Inc
- LifeSense Group
- Lumenis Ltd
- Maven Clinic
- Kindbody Fertility & Women’s Health
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
